Skip to main content
. 2019 Apr 12;11(4):e4446. doi: 10.7759/cureus.4446

Figure 1. (A) Magnetic resonance imaging (MRI) of the brain with/without contrast showing new metastatic hemorrhagic lesion in the right cerebral hemisphere as compared to MRI of the brain with/without contrast (B) done after five months of treatment with pembrolizumab.

Figure 1